Looking for a Winner Between Long-term TAVI Trials? Don't, Experts Urge
Directly comparing PARTNER 3 and Evolut Low Risk results is like “discussing reincarnation,” one prominent statistician warns.
Source: tctmd.com
Stay updated with breaking news from Michaela Borger. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Directly comparing PARTNER 3 and Evolut Low Risk results is like “discussing reincarnation,” one prominent statistician warns.
Endocarditis can present with many different clinical scenarios, so making the diagnosis can be challenging, says a co-chair of newly issued European guidelines for managing this disease.
Germany: Valve-in-valve TAVR yields better short-term mortality compared to redo surgical aortic valve replacement (rAVR), according to results from a meta-analysis of observational studies featured...